Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

NCT04781998 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Mental Disorder
Metabolic Disturbance
Feasibility
Overweight and Obesity
Liraglutide

Interventions

DRUG: liraglutide 3 mg (Saxenda®) once-daily

Sponsor

Anders Fink-Jensen, MD, DMSci